BeStock  
Stocks › Medical Instruments & Supplies › ALC

Alcon ALC

US equityMarket cap rank #435Medical Instruments & Supplies
$63.60 −$1.15 (-1.78%)
Market open · Oct 1, 1:20 pm ET · After hours $64.75 0.00%
Open$64.65
Prev close$64.75
Day range$63.40 – $64.82
Volume1.19M
Market cap$30.74B
P/E (TTM)48.5
Dividend yield0.56%

ALC Stock News

Headlines matching Alcon or the ALC ticker, most recent first.

  • Jefferies Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $85Market news · 23 Sep 2026
  • Stifel Maintains Alcon(ALC.US) With Hold RatingMarket news · 22 Sep 2026
  • Berenberg Bank Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $104.49Market news · 11 Sep 2026
  • Deutsche Bank Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $90Market news · 18 Aug 2026
  • UBS Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $102.03Market news · 14 Aug 2026
  • J.P. Morgan Downgrades Alcon(ALC.US) to Hold Rating, Cuts Target Price to $78.4Market news · 13 Aug 2026
  • J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)TipRanks · 13 Aug 2026
  • Mizuho Securities Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $85Market news · 13 Aug 2026
  • Needham Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $98Market news · 12 Aug 2026
  • William Blair Maintains Alcon(ALC.US) With Hold RatingMarket news · 12 Aug 2026
  • Needham Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $95Market news · 11 Aug 2026
  • BofA Securities Maintains Alcon(ALC.US) With Sell Rating, Cuts Target Price to $59.41Market news · 22 Jul 2026
  • Mizuho Securities Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $80Market news · 16 Jul 2026
  • Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN), Immunome (IMNM) and Alcon (ALC)TipRanks · 12 Jun 2026
  • KeyBanc Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $88Market news · 12 Jun 2026

Discussion

No comments yet — be the first to weigh in on ALC.

Leave a comment

Scroll to Top